Fenofibrate
Brand name: Fenofibrate
Rank #390 of 500 drugs by total cost
$24.2M
Total Cost
670,936
Total Claims
$24.2M
Total Cost
24,023
Prescribers
$36
Cost per Claim
80,738
Beneficiaries
1,574,534
30-Day Fills
$1,008
Avg Cost/Provider
28
Avg Claims/Provider
About Fenofibrate
Fenofibrate (sold as Fenofibrate) was prescribed 670,936 times by 24,023 Medicare Part D providers in 2023, costing the program $24.2M. At $36 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 387 | Pegfilgrastim (Neulasta) | $24.4M | 3,096 |
| 388 | Linagliptin/Metformin Hcl (Jentadueto) | $24.3M | 33,018 |
| 389 | Ocrelizumab (Ocrevus) | $24.2M | 639 |
| 390 | Fenofibrate (Fenofibrate) | $24.2M | 670,936 |
| 391 | Empaglifloz/Linaglip/Metformin (Trijardy Xr) | $23.9M | 28,001 |
| 392 | Fluticasone Furoate (Arnuity Ellipta) | $23.7M | 74,825 |
| 393 | Lactulose (Lactulose) | $23.6M | 538,677 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology